1. Home
  2. IOT vs BBIO Comparison

IOT vs BBIO Comparison

Compare IOT & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Samsara Inc.

IOT

Samsara Inc.

HOLD

Current Price

$31.68

Market Cap

15.8B

Sector

Technology

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$69.44

Market Cap

15.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOT
BBIO
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8B
15.3B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
IOT
BBIO
Price
$31.68
$69.44
Analyst Decision
Buy
Strong Buy
Analyst Count
12
24
Target Price
$45.42
$83.00
AVG Volume (30 Days)
8.3M
2.8M
Earning Date
06-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
48.15
N/A
EPS
N/A
N/A
Revenue
$1,249,199,000.00
$502,076,000.00
Revenue This Year
$19.67
$88.86
Revenue Next Year
$19.62
$74.11
P/E Ratio
N/A
N/A
Revenue Growth
33.26
126.26
52 Week Low
$23.38
$28.33
52 Week High
$48.41
$84.94

Technical Indicators

Market Signals
Indicator
IOT
BBIO
Relative Strength Index (RSI) 56.05 49.17
Support Level $23.76 $61.95
Resistance Level $36.04 $79.56
Average True Range (ATR) 1.59 3.33
MACD 0.57 0.53
Stochastic Oscillator 66.68 50.86

Price Performance

Historical Comparison
IOT
BBIO

About IOT Samsara Inc.

Samsara Inc provides an end-to-end solution for operations. The company's Connected Operations Platform consolidates data from its IoT devices and a growing ecosystem of connected assets and third-party systems, and makes it easy for organizations to access, analyze, and act on data insights using its cloud dashboard, custom alerts and reports, mobile apps, and workflows.. The company derives almost all of its revenue from subscription services. Geographically, it derives a majority of its revenue from the United States. The company's customers ranges from small and medium-sized businesses to state and local governments.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: